Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)

Tekijä Nieto, Y
Julkaisussa Breast Cancer Res (2005)

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients trea...

Tekijä Nieto, Y, Woods, J, Nawaz, F, Baron, A, Jones, R B, Shpall, E J, Nawaz, S
Julkaistu 2007

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines

Tekijä Valdez, B C, Zander, A R, Song, G, Murray, D, Nieto, Y, Li, Y, Champlin, R E, Andersson, B S
Julkaistu 2014

Romidepsin targets multiple survival signaling pathways in malignant T cells

Tekijä Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S
Julkaisussa Blood Cancer J (2015)

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Tekijä Nieto, Y., Tu, S.-M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Julkaisussa Ann Oncol (2015)

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Tekijä Nieto, Y., Tu, S. -M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Julkaisussa Ann Oncol (2015)

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

Tekijä Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Julkaisussa Bone Marrow Transplant (2011)

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignanci...

Tekijä Kebriaei, P, Madden, T, Kazerooni, R, Wang, X, Thall, P, Ledesma, C, Nieto, Y, shpall, EJ, Hosing, C, Qazilbash, M, Popat, U, Khouri, I, Champlin, RE, Jones, RB, Andersson, BS
Julkaistu 2010

Intravenous Busulfan Plus Melphalan: An Effective, Chemotherapy-only Transplant Conditioning Regimen in Patients with Acute Lymphoblastic Leukemia

Tekijä Kebriaei, P, Madden, T, Wang, X, Thall, PF, Ledesma, C, de Lima, M, Shpall, EJ, Hosing, C, Qazilbash, M, Popat, U, Alousi, A, Nieto, Y, Champlin, RE, Jones, RB, Andersson, BS
Julkaisussa Bone Marrow Transplant (2012)

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantat...

Tekijä Kebriaei, P, Basset, Roland, Ledesma, C, Ciurea, S, Parmar, S, Shpall, EJ, Hosing, C, Khouri, Issa, Qazilbash, M, Popat, U, Alousi, A, Nieto, Y, Jones, RB, de Lima, M, Champlin, RE, Andersson, BS
Julkaisussa Biol Blood Marrow Transplant (2012)

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution

Tekijä Hosing, C., Bassett, R., Dabaja, B., Talpur, R., Alousi, A., Ciurea, S., Popat, U., Qazilbash, M., Shpall, E. J., Oki, Y., Nieto, Y., Pinnix, C., Fanale, M., Maadani, F., Donato, M., Champlin, R., Duvic, M.
Julkaisussa Ann Oncol (2015)

High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplant in Patients with Refractory Lymphoid Malignancies

Tekijä Nieto, Y, Thall, P, Valdez, B, Andersson, B, Popat, U, Anderlini, P, Shpall, EJ, Bassett, R, Alousi, A, Hosing, C, Kebriaei, P, Qazilbash, M, Gulbis, A, Chancoco, C, Bashir, Q, Ciurea, S, Khouri, I, Parmar, S, Shah, N, Worth, L, Rondon, G, Champlin, R, Jones, RB
Julkaistu 2012

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Tekijä Cheah, C. Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N. H., Romaguera, J. E., Turturro, F., Hagemeister, F. B., Fayad, L. E., Wang, M., Neelapu, S. S., Nastoupil, L. J., Westin, J. R., Rodriguez, M. A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M. A.
Julkaisussa Ann Oncol (2016)

Clofarabine Plus Busulfan Is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-term Study...

Tekijä Kebriaei, P., Bassett, R., Lyons, G., Valdez, B., Ledesma, C., Rondon, G., Oran, B., Ciurea, S., Alousi, A., Popat, U., Patel, K., Ahmed, S., Olson, A., Bashir, Q., Shah, N., Jones, R., Marin, D., Rezvani, K., Nieto, Y., Khouri, I., Qazilbash, M., Hosing, C., Shpall, E., Champlin, R.E., Andersson, B. S.
Julkaisussa Biol Blood Marrow Transplant (2016)

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Tekijä Srour, S. A., Singh, H., McCarty, J., de Groot, E., Huls, H., Rondon, G., Qazilbash, M., Ciurea, S., Bardelli, G., Buck, J., Alousi, A., Nieto, Y., Rezvani, K., Marin, D., Popat, U., Hosing, C., Shpall, E. J., Wierda, W. G., Kantarjian, H., Champlin, R. E., Cooper, L. J., Kebriaei, P.
Julkaisussa Blood (2020)